These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24046934)

  • 1. Decontamination technology: the missing element.
    Rahe H
    Int J Pharm Compd; 2013; 17(3):193-9. PubMed ID: 24046934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.
    Ligugnana R
    Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basics of sterile compounding: compounding by weight versus compounding by volume.
    Thoma L
    Int J Pharm Compd; 2014; 18(2):131-4. PubMed ID: 24881117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment.
    Sabatini L; Paolucci D; Marinelli F; Pianetti A; Sbaffo M; Bufarini C; Sisti M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e63-e68. PubMed ID: 32296508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of the aseptic processing environment.
    Frieben WR
    Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality Assurance and Quality Control, Part 2.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blueprint for implementing USP chapter 797 for compounding sterile preparations.
    Kastango ES;
    Am J Health Syst Pharm; 2005 Jun; 62(12):1271-88. PubMed ID: 15947127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A needle-free reconstitution and transfer system for compounded sterile intravenous drug solutions in compliance with United States Pharmacopeia Chapter <797> standards.
    Marks Z
    Int J Pharm Compd; 2014; 18(2):94-9. PubMed ID: 24881111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of risk for sterile preparations.
    ben-Horin SF; Rousso T
    Int J Pharm Compd; 2014; 18(1):30-4. PubMed ID: 24881337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterility of extemporaneously compounded preservative-free injections.
    Levchuk JW
    Am J Hosp Pharm; 1991 Jan; 48(1):71-2. PubMed ID: 2053941
    [No Abstract]   [Full Text] [Related]  

  • 16. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1.
    Martin M
    Int J Pharm Compd; 2018; 22(5):401-404. PubMed ID: 30384338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities.
    Weller T; Kragseth R; Dullinger R; Illum H; Perry A
    Int J Pharm Compd; 2015; 19(3):182-92. PubMed ID: 26714359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.